Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

UW TAN Study of Metastatic Urothelial Carcinoma

ABSTRACT:

Patients with metastatic urothelial carcinoma treated at our institution, who elected to undergo rapid autopsy at the time of death, are included in this study. These patients agreed to submit their tissue (normal samples for germline analysis [kidney or liver] as well as primary and metastatic tumor sites [urothelial carcinoma]) and the time of autopsy. Each patient signed consent to allow study of these tissues including histologic, sequencing (DNA/RNA), and implantation in to animals as able for future study.

PROVIDER: phs001797 | dbGaP |

REPOSITORIES: dbGaP

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	GapExchange_phs001797.v1.p1.xml	Xml
	dbGaPEx2.1.5.xsd	Other
	Study_Report.phs001797.MetastaticBladderCancer_Chemo.v1.p1.MULTI.pdf	Pdf
	manifest_phs001797.MetastaticBladderCancer_Chemo.v1.p1.c1.HMB-PUB-MDS.pdf	Pdf
	datadict_v2.xsl	Other

Items per page:

1 - 5 of 15

Similar Datasets

Predicting the evolution of metastatic disease in breast cancer: results from 50 years of autopsies

Project description:This is a genomic analysis of breast cancer metastasis using array based CGH and is part of a large study investigating the patterns and evolution of metastases from breast cancer using autopsy material accumulated over the last 50 years from a single institution. The samples used in the genomic profiling comprise the primary breast tumour and multiple matched metastases from each patient. The data demonstrate both the clonal nature of metastatic progression and the role of clonal evolution during progression. This study comprises six patients who died of metastatic breast cancer. For some patients the breast primary tumour and lymph node metastasis was obtained from previous surgical excision, otherwise material was obtained from a resulting autopsy. Each patient set of samples involves the primary breast tumour and multiple metastases, including from lung, liver, lymph node, adrenal gland, brain etc. DNA was extracted from formalin fixed paraffin embedded (FFPE) tissue blocks and analysed for DNA copy number alterations using an Agilent aCGH platform.

2013-11-11 | E-GEOD-46826 | biostudies-arrayexpress

Predicting the evolution of metastatic disease in breast cancer: results from 50 years of autopsies

2013-11-11 | GSE46826 | GEO

Serum peptidome profiles in metastatic and non-metastatic feline mammary carcinoma

Project description:Feline mammary carcinoma (FMC) is a common cancer found in female cats. Early detection is necessary to prevent both local and distant metastasis and increase survival times. However, the available protein biomarkers involved in non-metastatic FMC (NmFMC) and metastatic FMC (mFMC) are limited. The purpose of this study was to identify serum peptidome profiles in NmFMC and mFMC using liquid chromatography-tandem mass spectrometry.

2023-08-09 | PXD035906 | JPOST Repository

Tissue proteomics reveals potential metastatic and histopathological candidates for feline mammary carcinoma

Project description:Feline mammary carcinoma (FMC) is a prevalent and aggressive cancer with high metastatic potential. Few tissue biomarkers have been reported to help evaluate disease progression in FMC. This study aimed to analyze the tissue proteomic profiles of metastatic feline mammary carcinoma (mFMC) and non-metastatic FMC (NmFMC) across various histological grades (HGs) and histological types (HTs) using liquid chromatography-tandem mass spectrometry (LC-MS/MS).

2024-06-19 | PXD053213 | JPOST Repository

Expression data from human metastatic adrenocortical carcinoma

Project description:CXCR4 expression by metastatic adrenocortical carcinoma is heterogeneous among patients and among lesions We used microarrays for 57 ACC metastases from 42 patients to evaluate gene expression in different lesions from same patients and over time, focusing on CXCR4 expression and other genes correlating with CXCR4 expression

2017-11-24 | GSE90713 | GEO

Genomic distinctions between metastatic lower and upper tract urothelial carcinoma revealed through rapid autopsy

Project description:Genomic distinctions between metastatic lower and upper tract urothelial carcinoma revealed through rapid autopsy

| PRJNA528123 | ENA

Genomic distinctions between metastatic lower and upper tract urothelial carcinoma revealed through rapid autopsy

Project description:Genomic distinctions between metastatic lower and upper tract urothelial carcinoma revealed through rapid autopsy

| PRJNA528124 | ENA

Transcriptomic profiling of primary and unmatched lung metastatic clear cell Renal Cell Carcinoma

Project description:To understand the tumor immune microenvironment (TIME), we sequenced CD45+ tumor infiltrating leukocytes (TILs) isolated from three primary and three lung metastatic clear cell renal cell carcinoma (ccRCC) specimens.

2024-12-06 | GSE267835 | GEO

microRNA Profiling in Metastatic Renal Cell Carcinoma

Project description:We performed a microRNA (miRNA) microarray on 10 metastatic RCC tumors and compared differential miRNA expresison to 19 primary clear cell renal cell carcinomas (ccRCC). We found there were 65 significantly dysregulated miRNAs; 9 miRNAs were significantly upregulated and 56 miRNAs were significantly downregulated in metastatic RCC when compared to primary clear cell renal cell carcinoma. miRNA microarray was performed on 10 metastatic RCC tumors

2012-08-13 | E-GEOD-39440 | biostudies-arrayexpress

microRNA Profiling in Metastatic Renal Cell Carcinoma

2012-08-14 | GSE39440 | GEO